A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta

Published:2002-11 Issue:6 Volume:9 Page:645-655
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Paolillo A.,Pozzilli C.,Giugni E.,Tomassini V.,Gasperini C.,Fiorelli M.,Mainero C.,Horsfield M.,Galgani S.,Bastianello S.,Buttinelli C.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1468-1331.2002.00476.x/fullpdf

Reference38 articles.

1. A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

2. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

3. Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

4. Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI

5. Interferon-beta -1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study;Journal of Neurology;2017-06-09

2. Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics;Journal of Neuroimaging;2016-03-02

3. Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing−remitting multiple sclerosis;European Journal of Neurology;2016-01-24

4. Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial;BMC Neurology;2015-11-11

5. Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis;Journal of Managed Care & Specialty Pharmacy;2015-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3